Not available
Quote | CytomX Therapeutics Inc. (NASDAQ:CTMX)
Last: | $2.19 |
---|---|
Change Percent: | -0.47% |
Open: | $2.12 |
Close: | $2.19 |
High: | $2.2 |
Low: | $2.08 |
Volume: | 590,298 |
Last Trade Date Time: | 03/27/2024 03:00:00 am |
News | CytomX Therapeutics Inc. (NASDAQ:CTMX)
SOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced the appointment of Zhen Su, M.D., M.B.A., an experienced physician executive and leader in the developme...
- Initiation of GLP toxicology study for the first clinical candidate in the collaboration triggers a $5 million milestone payment to CytomX - - Program is one of several ongoing collaboration projects in broad CytomX-Astellas alliance on T-cell engaging bispecifics - - Cyto...
Message Board Posts | CytomX Therapeutics Inc. (NASDAQ:CTMX)
Subject | By | Source | When |
---|---|---|---|
Price gaining up | alstocks | investorshub | 06/28/2023 3:51:30 PM |
$CTMX and the shorts continue | alstocks | investorshub | 06/28/2023 8:32:04 AM |
Price trading up | TheFinalCD | investorshub | 06/24/2023 9:54:22 AM |
$CTMX MomentumIts now | Triple nickle | investorshub | 06/23/2023 4:28:00 AM |
MomentumIts gaining up | alexjames81 | investorshub | 06/20/2023 8:24:35 PM |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of conditionally ...
SOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced the appointment of Zhen Su, M.D., M.B.A., an experienced physician executive and leader in the developme...
- Initiation of GLP toxicology study for the first clinical candidate in the collaboration triggers a $5 million milestone payment to CytomX - - Program is one of several ongoing collaboration projects in broad CytomX-Astellas alliance on T-cell engaging bispecifics - - Cyto...